The Scientist

» drug development, microbiology and evolution

Most Recent

image: Lightning-Fast Spider Bites

Lightning-Fast Spider Bites

By | April 8, 2016

Trap-jaw spiders have the fastest, most powerful bite of any arachnid, scientists show. 

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: Accomplished Biophysicist Dies

Accomplished Biophysicist Dies

By | April 5, 2016

Harold Morowitz, who dedicated his career to investigating the origins of life, has passed away at age 88.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

In recent years, research has demonstrated that microbes living in and on the mammalian body can affect cancer risk, as well as responses to cancer treatment.

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: Startup Licenses “Vaginal Seeding” Approach

Startup Licenses “Vaginal Seeding” Approach

By | March 31, 2016

Boston-based Commense plans to develop microbial and nonmicrobial interventions aimed at improving child health.

0 Comments

image: Another Drug Price Hike

Another Drug Price Hike

By | March 28, 2016

Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

image: Contacts May Affect Eye Microbiome

Contacts May Affect Eye Microbiome

By | March 23, 2016

The bacterial communities in the eyes of contact lens wearers resemble those of the skin, according to a study. 

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech